Cyclobutylamine → HCID 67421123, compound
Reaction equation
[CH3:1][C:2]1[O:6][N:5]=[C:4]([C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=2)[C:3]=1[C:13]1[N:14]=[CH:15][N:16]([C:18]2[CH:26]=[CH:25][C:21]([C:22](O)=[O:23])=[CH:20][CH:19]=2)[CH:17]=1.[CH:27]1([NH2:31])[CH2:30][CH2:29][CH2:28]1>>[CH:27]1([NH:31][C:22](=[O:23])[C:21]2[CH:25]=[CH:26][C:18]([N:16]3[CH:17]=[C:13]([C:3]4[C:4]([C:7]5[CH:8]=[CH:9][CH:10]=[CH:11][CH:12]=5)=[N:5][O:6][C:2]=4[CH3:1])[N:14]=[CH:15]3)=[CH:19][CH:20]=2)[CH2:30][CH2:29][CH2:28]1Participants
3
Procedure
As described for Example 71c, 4-[4-(5-methyl-3-phenyl-isoxazol-4-yl)-imidazol-1-yl]-benzoic acid (100 mg, 0.29 mmol) was converted, using cyclobutylamine instead of cyclopropylmethylamine, to the title compound (13 mg, 11%) which was obtained as an off-white solid. MS: m/e=398.9 [M+H]+.
Sources & evidence
- ORD record
- ord-1b7dedd275c6466f8fe8c56a53774267
- Source dataset
- uspto-grants-2008_08
- Patent number
- US07414061B2
Reaction notes
Loading…